Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy

Hoppe, Stéphanie, Rainfray, Muriel, Fonck, Marianne, Hoppenreys, Laurent, Blanc, Jean-Frédéric, Ceccaldi, Joël, Mertens, Cécile, Blanc-Bisson, Christèle, Imbert, Yves, Cany, Laurent, Vogt, Luc, Dauba, Jérôme, Houédé, Nadine, Bellera, Carine A., Floquet, Anne, Fabry, Marie-Noëlle, Ravaud, Alain, Chakiba, Camille, Mathoulin-Pélissier, Simone, Soubeyran, Pierre·2013·Journal of Clinical Oncology

Abstract

Purpose: To determine factors associated with early functional decline during first-line chemotherapy in older patients. Patients and Methods: Patients age ≥ 70 years receiving first-line chemotherapy for cancer were prospectively considered for inclusion across 12 centers in France. Functional decline was defined as a decrease of ≥ 0.5 points on the Activities of Daily Living (ADL) scale between the beginning of chemotherapy and the second cycle. Factors associated with functional decline were sought from pretreatment abbreviated comprehensive geriatric assessment, including ADL, Instrumental ADL (IADL), Mini-Nutritional Assessment (MNA), Mini–Mental State Examination (MMSE), Geriatric Depression Scale (GDS15), and Timed Get Up and Go (GUG) test, and from comorbidities (Cumulative Illness Rating Scale–Geriatrics), MAX2 index, and baseline biologic and clinical information. Results: Of 364 included patients, 50 experienced functional decline (16.7%; median, 0.5 points). Abnormal preadmission performance status, IADL, GDS15, MMSE, GUG, and MNA were associated with increased likelihood of functional decline (univariate analysis). In the multivariate model adjusted for baseline ADL and MAX2 index, high baseline GDS (odds ratio [OR], 2.16; 95% CI, 1.09 to 4.30; P = .03) and low IADL scores (OR, 2.87; 95% CI, 1.06 to 7.79; P = .04) were independently associated with increased risk of functional decline. Conclusion: Our results outline associations between baseline depression, instrumental dependencies, and early functional decline during chemotherapy for older patients. ADL should be sequentially evaluated early during treatment. Baseline evaluation of GDS15 and IADL may be proposed to anticipate this event.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2012.47.7430

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 236

Metadata

Authors
Hoppe, S., Rainfray, M., Fonck, M., Hoppenreys, L., Blanc, J.-F., Ceccaldi, J., Mertens, C., Blanc-Bisson, C., Imbert, Y., Cany, L., Vogt, L., Dauba, J., Houédé, N., Bellera, C. A., Floquet, A., Fabry, M.-N., Ravaud, A., Chakiba, C., Mathoulin-Pélissier, S., & Soubeyran, P.
Venue
Journal of Clinical Oncology
Published
2013-11-01
Volume
31
Issue
31
Pages
3877-3882
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2167568167
Cited by
236
References
9
FWCI
6.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. https://app.cochat.ai/papers/10.1200/jco.2012.47.7430
The paper
Hoppe, S., Rainfray, M., Fonck, M., Hoppenreys, L., Blanc, J.-F., Ceccaldi, J., Mertens, C., Blanc-Bisson, C., Imbert, Y., Cany, L., Vogt, L., Dauba, J., Houédé, N., Bellera, C. A., Floquet, A., Fabry, M.-N., Ravaud, A., Chakiba, C., Mathoulin-Pélissier, S., & Soubeyran, P. (2013). Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2012.47.7430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.